130 participants
A Study Evaluating the Safety and Efficacy of GLPG5101 (19CP02) in Participants With Non-Hodgkin Lymphoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-06-30
- Start Date:
- 2022-03-09
- Completion:
- 2026-05-27
Conditions
- Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
- Lymphomas Non-Hodgkin&Amp;Amp;#39;s B-Cell
Interventions
- GENETIC
No Results Yet